Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that ...

Immune cells in the brain that go rogue contribute to the death of neurons, so getting rid of them may slow the progression of neurodegenerative conditions like amyotrophic lateral sclerosis ...

In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to ...

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't ...

Scientists have identified a crucial mechanism that allows plants to shape their vascular systems, determining whether they grow soft edible storage organs or develop the rigid woody tissue ...

A shift toward personalized treatments and programmable cell therapies opens new doors for scientists engineering T cell-based treatments.

Researchers from Tr1x Inc. presented the development of TRX-319, a novel allogeneic regulatory T-cell therapy designed for the treatment of autoimmune disorders.

Ever since 6-year-old Emily Whitehead became the first pediatric patient to receive CAR-T cell therapy in 2012, when T cells ...

CAR T-cell therapy for lupus is still in Phase 1 trials but if all continues to go well, Desai said it could be about five to 10 years before it's available to more lupus patients. Renihan's son, Owen ...

In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete ...

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...